In the News

1853 News Items found
Physician-scientist Piro Lito
In the Lab
Recently developed targeted drugs used to treat lung cancer are only partially effective. Scientists now know why.
Lisa DeAngelis
Feature
Meet Lisa DeAngelis, MSK's new Physician-in-Chief. She discusses her upbringing, her early career at MSK, and her top priorities as physician-in-chief.
Learn more about Ken Manotti, who leads philanthropic fundraising efforts at Memorial Sloan Kettering Cancer Center, where he is a Senior Vice President and Chief Development Officer.
Sandy wearing an orange tank top and running.
Read about Sandy Freiberg, who ran a marathon to honor his brother, Evan, who is in his fifth year of cancer treatment at Memorial Sloan Kettering.
Richard Nixon with Benno and Nancy Schmidt
In 1971, Richard Nixon launched a “war on cancer.” It’s still raging.
Philipp Niethammer
Cell biologists are finding surprising overlaps between a particular form of programmed cell death and the process of wound detection.
Medical oncologist Alexander Drilon in a mask.
Taking Aim at Lung Cancer
For many people with lung cancer, targeted therapies can provide effective, long-term control of their disease with fewer side effects than chemotherapy.
Memorial Sloan Kettering Patient and Family Advisory Council for Quality members Eliza Weber and Kate Niehaus.
The Patient and Family Advisory Council for Quality (PFACQ) marks five years of ensuring the patient and family perspective is included in everything MSK does.
Zoom screenshot of Memorial Sloan Kettering staff.
MSK employees celebrate the 2020 African American Day Parade with a watch party.
Rihanna Plaza
Learn how our donor community supported MSK this year — and see what’s ahead for 2021.